GASTRIC MALT LYMPHOMA – CURRENT DIAGNOSTIC AND THERAPEUTIC STRATEGIES
Open Access
- 30 December 2025
- journal article
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (4(48))
Abstract
Gastric mucosa-associated lymphoid tissue (MALT) lymphoma is a distinct subtype of extranodal marginal zone B-cell lymphoma strongly associated with Helicobacter pylori infection. This review presents an overview of current diagnostic and therapeutic strategies, highlighting recent developments in molecular diagnostics and evidence-based management. The diagnosis relies on histopathological evaluation supported by immunohistochemistry and molecular testing for characteristic translocations, particularly t(11;18)(q21;q21). First-line therapy remains H. pylori eradication, which induces complete and durable remission in most patients, including some who are H. pylori-negative. For those unresponsive to antibiotics, radiotherapy or rituximab-based immunotherapy achieves excellent local control and survival rates. Prognosis is generally favourable, with five-year overall survival exceeding 90%. However, complications such as gastrointestinal bleeding, perforation, and histologic transformation into diffuse large B-cell lymphoma (DLBCL) may occur. Early detection, accurate staging, and an individualized, risk-adapted therapeutic approach remain key factors influencing long-term outcomes. Advances in endoscopic imaging, molecular characterization, and targeted therapies continue to refine the management of gastric MALT lymphoma, supporting the trend toward more personalized treatment strategies and improved patient prognosis.Keywords
This publication has 72 references indexed in Scilit:
- Involvement of non-Helicobacter pylori helicobacter infections in Helicobacter pylori-negative gastric MALT lymphoma pathogenesis and efficacy of eradication therapyGastric Cancer, 2021
- Latest trends in the incidence of Helicobacter pylori-uninfected gastric mucosa-associated lymphoid tissue lymphoma at the Cancer Institute Hospital, JapanInternational Journal of Hematology, 2021
- Bendamustine‐rituximab regimen in untreated indolent marginal zone lymphoma: experience on 65 patientsHematological Oncology, 2020
- Favorable radiation field decrease in gastric marginal zone lymphomaStrahlentherapie und Onkologie, 2019
- Spontaneous perforation of primary gastric B‐cell lymphoma of MALT: a case report and literature reviewClinical Case Reports, 2016
- Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-upAnnals of Hematology, 2015
- Long‐term outcome in localized extranodal mucosa‐associated lymphoid tissue lymphomas treated with radiotherapyCancer, 2010
- Primary gastric lymphoma. A clinicopathologic study of 233 cases with special reference to evaluation with the MIB-1 indexCancer, 1995
- Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissueCancer, 1984
- Primary gastric lymphoma. An analysis with emphasis on prognostic factors and radiation therapyCancer, 1983